Diagnosis of prostate cancer, mortality decreases around the world, says the study.
Researchers looked at data from the World Health Organization on the continent from 1980 to 2012 and saw an encouraging trend. In most parts of the world, the number of men diagnosed with dying from prostate cancer has decreased or stabilized, according to a study presented Tuesday at a meeting of the American Cancer Research Association in Atlanta
. The bladder of the prostate secretes the seminal fluid, which provides nutrition for and allows you to transport sperm.
dr. Alex Christie, vice chairman of the US Preventive Services Working Group and Professor of Family Medicine and Health at the University of Virginia Commonwealth who did not participate in the study, explained that prostate cancer "is one of the most common types of cancer that The prostate cancer is growing slowly. "
A new study notes that prostate cancer is the second leading cause of cancer diagnosis and the sixth most common cause of death from cancer among men around the world. noted that since 201
2, prostate cancer has led to cancer in men or new diagnoses in 96 countries, and this is the most common cause of death among men in 51 countries.
"By comparing rates from different countries, we can estimate differences in the methods of detection and improvement in treatment," – said Marybeth Freeman, lead author of the study and senior research fellow in surveillance research in American Cancer Society. "Previous studies pointed to a significant difference in the frequency of prostate cancer due to factors, including the practice of detection, availability of treatment and genetic factors." The level of prostate cancer diagnosis has decreased in seven countries from 2008 to 2012, while 33 countries have shown a stabilization of diagnostic rates. From 2008 to 2012, the United States most reduced the number of men diagnosed with prostate cancer.
Freeman and colleagues found that these results are encouraging and suggest that the study supports the use of specific antigen progenitor antigens screening. In low-income countries, where screening is less affordable, later diagnosis and increased mortality rates are more widespread, she said.
Countries with most prostate cancer cases from 2008 to 2012 were Brazil, Lithuania and Australia. The highest mortality rates from prostate cancer include the Caribbean, such as Barbados, Trinidad and Tobago, as well as Cuba, as well as South Africa, Lithuania, Estonia and Latvia.
. A revolution in the management of prostate cancer, it is not perfect. There is a risk of excessive diagnosis and overwork.
"The current recommendations of the US Preventive Services Working Group say that the decision whether screening for prostate cancer in men aged 55 to 69 should be made individual, made only after discussing the benefits and harm for – said Christ. "Men 70 years of age and older should not undergo screening for prostate cancer because the damage prevails over the age group."
Although Freeman acknowledges the limitations in the amount of data and how they were collected, she claims that in as a whole INSTITUTING gives a comprehensive look at prostate cancer in the world.
"Further studies should track the trends in mortality and late stages of the disease, to assess the impact of the reduction [prostate-specific antigen] testing in several countries," – she said.